OUR SOLUTION
CarciScan - Rethinking Prevention
A PCR-based HPV test kit designed for reliable early detection—simple to use, secure, and widely accessible.
The Problem We Solve
Why New Solutions Are Needed
Many women worldwide do not have regular access to gynecological screening. In numerous regions, there is a shortage of specialized physicians, adequate laboratory capacity, and structured screening programs. At the same time, high costs, long travel distances, and administrative barriers create additional obstacles—particularly in rural and low-income areas.
Cervical cancer can develop over many years without noticeable symptoms. Without regular screening, an HPV infection often remains undetected until advanced cellular changes or invasive tumors have already developed.
As a result, diagnoses are frequently made too late—despite the fact that timely HPV testing and targeted early detection could prevent the majority of cases.
There is a clear need for new, low-threshold and accessible solutions that enable reliable preventive care—regardless of a woman’s location, income, or healthcare infrastructure.
Making Early Detection Accessible
Our solution is grounded in scientific innovation and medical expertise.
In collaboration with a renowned professor and his partner, affordable HPV test kits were developed to enable early detection of cervical cancer. The goal is to make high-quality diagnostics accessible to all women—regardless of income or place of residence.
Through mobile testing units and regional screening programs, we bring preventive care directly to women. Physicians and healthcare professionals provide on-site education, consultations, and straightforward access to diagnostic services. This creates a low-threshold pathway to early cancer detection—even in regions with limited medical infrastructure.
How CarciScan Works
How to Use the Test Kit
Discrete Self-Sampling at Home
The sample is self-collected safely and independently in a familiar environment, eliminating the need for an immediate clinical appointment.
➔
The sample is securely packaged following the provided instructions and submitted to an accredited laboratory for PCR-based analysis.
➔
In an accredited laboratory, the sample undergoes high-sensitivity PCR-based analysis to identify clinically relevant high-risk HPV types.
➔
Test results are delivered securely and confidentially.
If indicated, appropriate follow-up with a healthcare professional is recommended.
Procedure at a Doctor’s Office or Hospital
The sample is collected as part of a gynecological examination by trained medical professionals.
➔
The sample is analyzed in a certified laboratory for high-risk HPV types, delivering over 95% accuracy.
➔
After collection, the sample is sent to a specialized laboratory where it is analyzed using HPV DNA PCR technology.
➔
If the result is positive, appropriate follow-up diagnostics or preventive measures are initiated in accordance with medical guidelines.
Medical Quality
Scientifically Validated
CarciScan is based on advanced PCR technology for the precise detection of high-risk HPV DNA.
This method enables the direct identification of clinically relevant virus types — even in the early stages of infection.
The test specifically targets high-risk HPV types such as HPV 16, 18, 31, 33, 45, and 52, as well as other clinically significant variants. This allows infections to be detected at an early stage — before serious cellular changes develop.
All analyses are conducted in qualified laboratories in accordance with international medical quality standards, ensuring a high level of diagnostic accuracy and reliability.
The Decisive Advantage
Simple. Accessible. Effective.
CarciScan combines medical precision with practical accessibility.
By enabling self-sampling, preventive care becomes available to women who previously had limited or no access to regular screening diagnostics.
This means:
- Early detection instead of late-stage treatment
- Prevention instead of emergency care
- Hope instead of uncertainty
The Next Step in Cancer Prevention
Early detection saves lives — but it must also be accessible.
With innovative PCR technology and flexible application options, CarciScan opens new pathways in cancer prevention.
Become part of this solution — advancing access to care, enabling earlier diagnoses, and strengthening sustainable health systems.
Join us in expanding access to modern cancer prevention. Contact us for more information or to explore potential collaboration.